Company intelligence
FUJIFILM Cellular Dynamics, Inc
The Power of Human Biology: Leveraging our human iPSC technology to revolutionize scientific research and cell therapy.
About FUJIFILM Cellular Dynamics, Inc
Fujifilm Cellular Dynamics, Inc. develops and manufactures biologically relevant human cells derived from induced pluripotent stem (iPS) cells. Our iCell® and donor-specific MyCell® Products are highly pure, highly reproducible, and available in industrial quantity to enable drug discovery, toxicity testing, stem cell banking, and cell therapy development.
Verified activity
Signals from FUJIFILM Cellular Dynamics, Inc
4 published signals
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc employee Nina Bauer, PhD MBA, EVP, Strategy and Commercial, participated in an interview with Drug Discovery News discussing how iPSCs are advancing toxicity testing, high-throughput screening, organoid development, and advanced therapies.
Reported by FUJIFILM Cellular Dynamics, Inc
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc will be attending the 6th Annual iPSC Drug Development Summit in Boston from September 9th and 10th.
Reported by FUJIFILM Cellular Dynamics, Inc
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc. served as guest editor for Cell & Gene Therapy Insights’ inaugural AI-focused edition.
Reported by Nina Bauer, PhD MBA
Presence & Recognition
FUJIFILM Cellular Dynamics, Inc. is hosting a discussion on September 3, 2026, with the Advanced Therapies Think Tank - AT3.
Reported by Nina Bauer, PhD MBA